Cargando…
Sprayable nanomicelle hydrogels and inflammatory bowel disease patient cell chips for development of intestinal lesion-specific therapy
All-in-one treatments represent a paradigm shift in future medicine. For example, inflammatory bowel disease (IBD) is mainly diagnosed by endoscopy, which could be applied for not only on-site monitoring but also the intestinal lesion-targeted spray of injectable hydrogels. Furthermore, molecular co...
Autores principales: | Yoon, Hyo-Jin, Lee, Songhyun, Kim, Tae Young, Yu, Seung Eun, Kim, Hye-Seon, Chung, Young Shin, Chung, Seyong, Park, Suji, Shin, Yong Cheol, Wang, Eun Kyung, Noh, Jihye, Kim, Hyun Jung, Ku, Cheol Ryong, Koh, Hong, Kim, Chang-Soo, Park, Joon-Sang, Shin, Young Min, Sung, Hak-Joon |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
KeAi Publishing
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8971598/ https://www.ncbi.nlm.nih.gov/pubmed/35415304 http://dx.doi.org/10.1016/j.bioactmat.2022.03.031 |
Ejemplares similares
-
O(2) variant chip to simulate site-specific skeletogenesis from hypoxic bone marrow
por: Kim, Hye-Seon, et al.
Publicado: (2023) -
The Protective Effect of Zebularine, an Inhibitor of DNA Methyltransferase, on Renal Tubulointerstitial Inflammation and Fibrosis
por: Koh, Eun Sil, et al.
Publicado: (2022) -
Inhibition of p300/CBP-Associated Factor Attenuates Renal Tubulointerstitial Fibrosis through Modulation of NF-kB and Nrf2
por: Chung, Sungjin, et al.
Publicado: (2019) -
Correction: Treatment combining aliskiren with paricalcitol is effective against progressive renal tubulointerstitial fibrosis via dual blockade of intrarenal renin
por: Chung, Sungjin, et al.
Publicado: (2018) -
Treatment combining aliskiren with paricalcitol is effective against progressive renal tubulointerstitial fibrosis via dual blockade of intrarenal renin
por: Chung, Sungjin, et al.
Publicado: (2017)